[Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors]

Autor:	W J, Zhu, H H, Zhu, Y T, Liu, L, Lin, P Y, Xing, X Z, Hao, M H, Cong, H Y, Wang, Y, Wang, J L, Li, Y, Feng, X S, Hu
Rok vydání:	2022
Předmět:	Lung Neoplasms Brain Neoplasms Carcinoma Non-Small-Cell Lung Programmed Cell Death 1 Receptor Humans Prognosis Immune Checkpoint Inhibitors B7-H1 Antigen Retrospective Studies
Zdroj:	Zhonghua zhong liu za zhi [Chinese journal of oncology]. 44(5)
ISSN:	0253-3766
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::eef43a91aaaef3c0f8b30f11cd26073e https://pubmed.ncbi.nlm.nih.gov/35615798 Zobrazit plný text záznamu